Genetic Screen: Hearing lessons from flies
The myosin motor proteins play a variety of roles inside cells, such as transporting cargo around the cell and maintaining the structure of the cell's internal skeleton. Myosins also make important contributions to our sense of hearing, which can be revealed by studying conditions such as Usher syndrome (a severe sensory disorder that causes congenital deafness and late-onset blindness). In humans and other mammals, two myosin proteins called myosin VIIa and myosin IIa have been linked to deafness, but we do not understand how these proteins interact.
Now, in eLife, Andrew Groves, Hugo Bellen and co-workers – including Tongchao Li of Baylor College of Medicine as first author – report evidence of a conserved molecular machinery in the auditory organs of mammals and the fruit fly Drosophila (Li et al., 2016). Furthermore, the screen identified an enzyme called Ubr3 that regulates the interaction of the two myosins in Drosophila.
Auditory organs convert the mechanical energy in sound waves into electrical signals that can be interpreted by the brain. In mammals, this conversion happens in "hair cells" in the inner ear. These cells have thin protrusions called stereocilia on their surface, and the tips of these stereocilia contain ion channels called MET channels (which is short for mechanoelectrical transduction channels).
Five proteins associated with the most serious form of Usher syndrome – known as USH1 – are key components of the molecular apparatus that enables the MET channels to open and close in response to mechanical force. The USH1 proteins are restricted to the tips of the stereocilia, where they form a complex (Figure 1; Prosser et al., 2008; Weil et al., 1995). Two of the USH1 proteins work together to join the tip of each stereocilium to its next-highest neighbor, forming bundles of stereocilia (Kazmierczak et al., 2007). Deflecting these bundles stretches the stereocilial bundles, which opens the MET channels and triggers the hair cell to produce an electrical signal (Pan and Zhang, 2012). Thus, the USH1 protein complex is essential for maintaining the structural integrity of stereocilia.
Flies do not have ears as such, but they are still able to detect sounds through their antennae. Despite the auditory organs of flies and mammals having different structures, they work in a similar way. In Drosophila, structures called scolopidia, which are found suspended in the second segment of the antenna, sense sound vibrations relayed from the third segment (Figure 1). Cells called cap cells and scolopale cells anchor the tip of the scolopidia to the joint between the second and third segments. The scolopale cells also secrete a protein to form the dendritic cap that connects a sensory neuron with the joint. This structure allows the mechanical forces produced by the sound waves to be transmitted to the neuron, activating the MET channels and causing the sensory neuron to produce an electrical signal.
Inactivating the gene that produces myosin VIIa causes the scolopidia to detach from the joint and causes the protein that forms the dendritic cap to be distributed abnormally (Todi et al., 2005; Todi et al., 2008). Now, Li at al. – who are based at Baylor, the Texas Children's Hospital, the University of Iowa and the University of Toronto – show that inactivating the gene that encodes the enzyme Ubr3 has the same effect.
Ubr3 is a type of E3 ubiquitin ligase. These enzymes regulate a number of cell processes by helping to join small proteins called ubiquitins onto other proteins. Using a forward genetic screen, Li et al. found that Ubr3 is enriched in the tips of scolopidia, particularly at the ends of the sensory neurons and in the scolopale cells closest to the joint between the second and third segments.
Li et al. show that Ubr3 and another E3 ubiquitin ligase called Cul1 negatively regulates the addition of a single ubiquitin to myosin II. This means that the loss of Ubr3 increases the rate of the “mono-ubiquitination” of myosin II, which leads to stronger interactions between myosin II and myosin VIIa. Importantly, the mono-ubiquitination of myosin II and the interaction between myosin II and myosin VIIa helps to ensure that they (and also the fly equivalents of Usher proteins) localize correctly to the scolopidial tip. Thus, Ubr3 is crucial for maintaining the structure and function of scolopidia.
Overall, the results presented by Li et al. argue that a conserved model underlies hearing in both Drosophila and mammals. In this model, the negative regulation of mono-ubiquitination of myosin IIa (or myosin II in the case of Drosophila) by Ubr3 promotes the formation of the myosin IIa-myosin VIIa complex (or the myosin II-myosin VIIa complex in Drosophila). The myosin complex then transports the USH1 protein complex to the tips of the stereocilia (or scolopidia) to establish the sound-sensing structure that enables the MET channels to work.
Using the power of fly genetics, Li et al. have identified new components involved in the development and function of auditory organs, and linked them to genes known to play a role in human deafness. Undoubtedly, future studies of these deafness-related genes in the Drosophila auditory organ will bring more insights into the interplay among the molecules, including the USH1 proteins, that are important for hearing.
References
-
The Drosophila auditory systemWiley Interdisciplinary Reviews: Developmental Biology 3:179–191.https://doi.org/10.1002/wdev.128
-
Mosaic complementation demonstrates a regulatory role for myosin VIIa in actin dynamics of stereociliaMolecular and Cellular Biology 28:1702–1712.https://doi.org/10.1128/MCB.01282-07
-
How the genetics of deafness illuminates auditory physiologyAnnual Review of Physiology 73:311–334.https://doi.org/10.1146/annurev-physiol-012110-142228
Article and author information
Author details
Publication history
Copyright
© 2016, Lee et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,047
- views
-
- 126
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
- Neuroscience
Experience shapes the brain as neural circuits can be modified by neural stimulation or the lack of it. The molecular mechanisms underlying structural circuit plasticity and how plasticity modifies behaviour are poorly understood. Subjective experience requires dopamine, a neuromodulator that assigns a value to stimuli, and it also controls behaviour, including locomotion, learning, and memory. In Drosophila, Toll receptors are ideally placed to translate experience into structural brain change. Toll-6 is expressed in dopaminergic neurons (DANs), raising the intriguing possibility that Toll-6 could regulate structural plasticity in dopaminergic circuits. Drosophila neurotrophin-2 (DNT-2) is the ligand for Toll-6 and Kek-6, but whether it is required for circuit structural plasticity was unknown. Here, we show that DNT-2-expressing neurons connect with DANs, and they modulate each other. Loss of function for DNT-2 or its receptors Toll-6 and kinase-less Trk-like kek-6 caused DAN and synapse loss, impaired dendrite growth and connectivity, decreased synaptic sites, and caused locomotion deficits. In contrast, over-expressed DNT-2 increased DAN cell number, dendrite complexity, and promoted synaptogenesis. Neuronal activity modified DNT-2, increased synaptogenesis in DNT-2-positive neurons and DANs, and over-expression of DNT-2 did too. Altering the levels of DNT-2 or Toll-6 also modified dopamine-dependent behaviours, including locomotion and long-term memory. To conclude, a feedback loop involving dopamine and DNT-2 highlighted the circuits engaged, and DNT-2 with Toll-6 and Kek-6 induced structural plasticity in this circuit modifying brain function and behaviour.
-
- Cell Biology
Platelet-derived growth factor receptor alpha (PDGFR-α) activity is crucial in the process of dental and periodontal mesenchyme regeneration facilitated by autologous platelet concentrates (APCs), such as platelet-rich fibrin (PRF), platelet-rich plasma (PRP) and concentrated growth factors (CGF), as well as by recombinant PDGF drugs. However, it is largely unclear about the physiological patterns and cellular fate determinations of PDGFR-α+ cells in the homeostasis maintaining of adult dental and periodontal mesenchyme. We previously identified NFATc1 expressing PDGFR-α+ cells as a subtype of skeletal stem cells (SSCs) in limb bone in mice, but their roles in dental and periodontal remain unexplored. To this end, in the present study we investigated the spatiotemporal atlas of NFATc1+ and PDGFR-α+ cells residing in dental and periodontal mesenchyme in mice, their capacity for progeny cell generation, and their inclusive, exclusive and hierarchical relations in homeostasis. We utilized CRISPR/Cas9-mediated gene editing to generate two dual recombination systems, which were Cre-loxP and Dre-rox combined intersectional and exclusive reporters respectively, to concurrently demonstrate the inclusive, exclusive, and hierarchical distributions of NFATc1+ and PDGFR-α+ cells and their lineage commitment. By employing the state-of-the-art transgenic lineage tracing techniques in cooperating with tissue clearing-based advanced imaging and three-dimensional slices reconstruction, we systematically mapped the distribution atlas of NFATc1+ and PDGFR-α+ cells in dental and periodontal mesenchyme and tracked their in vivo fate trajectories in mice. Our findings extend current understanding of NFATc1+ and PDGFR-α+ cells in dental and periodontal mesenchyme homeostasis, and furthermore enhance our comprehension of their sustained therapeutic impact for future clinical investigations.